Here’s the news straight from the press release –
Lilly’s Insulin Lispro Injection (the generic for Humalog), 100 units/mL — first introduced at half the list price of branded Humalog® (insulin lispro injection, 100 units/mL) in 2019 — will now have a 70 percent lower list price than Humalog U-100 starting January 1, 2022.
Insulin Lispro injection can be ordered through all U.S. retail pharmacies. People using any Lilly insulin – including Insulin Lispro Injection – can fill their monthly prescription for $35 through the Lilly Insulin Value Program for people with commercial insurance, or who are uninsured, and the Senior Savings Model for seniors in participating Medicare Part D plans.
Pharmacists can substitute Insulin Lispro Injection U-100 for Humalog U-100 without a new prescription because they are the same insulin. Any retail pharmacy that does not stock Insulin Lispro Injection can obtain it from a wholesaler in 1-2 days.
You can find more particulars on the press release. Personally, I haven’t yet calculated what this means to me. I do use Humalog, and because I don’t use a lot of insulin, I withdraw my dose from Humalog pen cartridges. I scrubbed vials for pens when I was throwing 2/3rds of the vial away after a month. And, when I get a script from my endo for the cartridges, I end up getting more cartridges than the 3 vials I would otherwise get, so for me, it lasts a lot longer.
All I know, is on the surface this seems encouraging that pharmaceutical companies are maybe